Franco Locatelli

71.2k total citations · 9 hit papers
1.0k papers, 33.0k citations indexed

About

Franco Locatelli is a scholar working on Hematology, Immunology and Oncology. According to data from OpenAlex, Franco Locatelli has authored 1.0k papers receiving a total of 33.0k indexed citations (citations by other indexed papers that have themselves been cited), including 510 papers in Hematology, 263 papers in Immunology and 230 papers in Oncology. Recurrent topics in Franco Locatelli's work include Hematopoietic Stem Cell Transplantation (312 papers), Acute Lymphoblastic Leukemia research (214 papers) and Immune Cell Function and Interaction (170 papers). Franco Locatelli is often cited by papers focused on Hematopoietic Stem Cell Transplantation (312 papers), Acute Lymphoblastic Leukemia research (214 papers) and Immune Cell Function and Interaction (170 papers). Franco Locatelli collaborates with scholars based in Italy, United States and Germany. Franco Locatelli's co-authors include Maria Ester Bernardo, Rita Maccario, Lorenzo Moretta, Marco Zecca, Willem E. Fibbe, Francesco Frassoni, Patrizia Comoli, Daniela Montagna, Alessandro Moretta and Alice Bertaina and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Nucleic Acids Research.

In The Last Decade

Franco Locatelli

968 papers receiving 32.5k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Mesenchymal stem cells for treatment of steroid-resistant, severe, acute graft-versus-host disease: a phase II study

2008 2.0k citations Franco Locatelli, Maria Ester Bernardo et al. profile →
Human Bone Marrow–Derived Mesenchymal Stem Cells Do Not Undergo Transformation after Long-termIn vitroCulture and Do Not Exhibit Telomere Maintenance Mechanisms

2007 539 citations Maria Ester Bernardo, Franco Locatelli et al. Cancer Research profile →
Autologous bone marrow-derived mesenchymal stromal cells in the treatment of fistulising Crohn's disease

2011 421 citations Maria Ester Bernardo, Franco Locatelli et al. profile →
Emapalumab in Children with Primary Hemophagocytic Lymphohistiocytosis

2020 311 citations Franco Locatelli, Simone Cesaro et al. profile →
Autophagy and cancer stem cells: molecular mechanisms and therapeutic applications

2019 298 citations Franco Locatelli et al. profile →
Ruxolitinib for Glucocorticoid-Refractory Chronic Graft-versus-Host Disease

2021 271 citations Robert Zeiser, Nicola Polverelli et al. profile →
Dabrafenib plus Trametinib in Pediatric Glioma with BRAF V600 Mutations

2023 125 citations Franco Locatelli et al. profile →
Advancements and challenges in CAR T cell therapy in autoimmune diseases

2024 85 citations Franco Locatelli et al. profile →
Blinatumomab Added to Chemotherapy in Infant Lymphoblastic Leukemia

2023 83 citations Gabriele Escherich, Franco Locatelli et al. profile →

Peers

Countries citing papers authored by Franco Locatelli

Since Specialization

Citations

This map shows the geographic impact of Franco Locatelli's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Franco Locatelli with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Franco Locatelli more than expected).

Fields of papers citing papers by Franco Locatelli

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Franco Locatelli. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Franco Locatelli. The network helps show where Franco Locatelli may publish in the future.

Co-authorship network of co-authors of Franco Locatelli

This figure shows the co-authorship network connecting the top 25 collaborators of Franco Locatelli. A scholar is included among the top collaborators of Franco Locatelli based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Franco Locatelli. Franco Locatelli is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	B-Cell-Depleting Immune Therapies as Potential New Treatment Options for Systemic Sclerosis 2025 ·SHILAP Revista de lepidopterología ·Gerhard Zugmaier, Matthias Klinger, Marion Subklewe, (unknown), Franco Locatelli	2
2	Prognostic Value of Molecular Genetic Measurable Residual Disease ( MRD ) Monitoring in Pediatric Acute Myeloid Leukemia Expressing KMT2A::MLLT10 2025 ·European Journal Of Haematology ·(unknown), (unknown), Mareike Rasche, Martina Pigazzi, Claudia Tregnago, (unknown), Christiane Walter, Michael Dworzak, Nora Mühlegger, Nils von Neuhoff, Franco Locatelli, Dirk Reinhardt, Markus Schneider	1
3	HLA alleles associated to susceptibility to gliptin‐associated bullous pemphigoid in Italian patients 2024 ·HLA ·Marco Andreani, Feliciana Mariotti, (unknown), Franco Locatelli, (unknown), (unknown), (unknown), Alessandra Scarabello, Barbara Bellei, Cristiana Di Campli, (unknown), (unknown), Anna Rita Giampetruzzi, Biagio Didona, Dario Pitocco, Clara De Simone, Giovanni Di Zenzo	2
4	Evaluation of Mobilization, Apheresis, and Conditioning Regimen and Engraftment in Patients Receiving One-Time Gene Therapy with Elivaldogene Autotemcel (Eli-cel) for Cerebral Adrenoleukodystrophy (CALD) 2024 ·Transplantation and Cellular Therapy ·Christine Duncan, Paul J. Orchard, Florian Eichler, Jörn‐Sven Kühl, Satiro De Oliveira, Adrian J. Thrasher, Robert Chiesa, Jean‐Hugues Dalle, Ami J. Shah, Franco Locatelli, Nicholas Smith, Juliana Folloni Fernandes, Hernán Amartino, Caroline A. Lindemans, Jack Zhao, Ajay Singh, (unknown), Vinod K. Prasad, Andrew C. Dietz, David A. Williams	1
5	Prognostic Role of Molecular MRD Variations during Treatment of Pediatric AML: A Retrospective AIEOP AML2013/01 Study 2023 ·Blood ·Martina Pigazzi, (unknown), Pietro Merli, (unknown), (unknown), Pamela Scarparo, Manuela Tumino, Simone Cesaro, Rosamaria Mura, Concetta Micalizzi, Claudia Tregnago, Carmelo Rizzari, Marco Zecca, Barbara Buldini, Franco Locatelli	1
6	Moderate Incidence but Striking Correlation with TBI of Secondary Malignancies after HSCT in Children with ALL: Long-Term Follow-up from the Prospective International BFM- and Forum-Trials 2023 ·Blood ·Ánita Lawitschka, Jean‐Hugues Dalle, Ulrike Pötschger, (unknown), Petr Sedláček, (unknown), Marianne Ifversen, Peter Švec, Jerry Stein, Tayfun Güngör, Jacek Toporski, Cristina Díaz de Heredia, Marc Bierings, Roland Meisel, Marc Ansari, Adriana Balduzzi, Franco Locatelli, Christina Peters, Peter Bader	0
7	Bioelectric Reprogramming of the Bone Marrow Niche in Acute Myeloid Leukemia 2023 ·Blood ·(unknown), (unknown), (unknown), (unknown), Giulia Borile, Alice Cani, (unknown), Mario Bortolozzi, Silvia Bresolin, Claudia Tregnago, Franco Locatelli, Martina Pigazzi	1
8	Safety and Efficacy Outcomes in Pediatric Patients with Transfusion-Dependent β-Thalassemia (TDT) Receiving Betibeglogene Autotemcel (beti-cel; LentiGlobin for β-thalassemia) Gene Therapy in the Phase 3 Hgb-207 (Northstar-2) and Hgb-212 (Northstar-3) Studies 2021 ·Transplantation and Cellular Therapy ·Mark C. Walters, Janet L. Kwiatkowski, John B. Porter, Suradej Hongeng, Evangelia Yannaki, Andreas E. Kulozik, Martin G. Sauer, Adrian J. Thrasher, Isabelle Thuret, Ashutosh Lal, Ruiting Guo, Weijian Liu, Richard A. Colvin, Franco Locatelli, Alexis A. Thompson	1
9	Ruxolitinib (RUX) Vs Best Available Therapy (BAT) in Patients (Pts) with Glucocorticoid-Refractory Chronic Graft-Vs-Host Disease (cGVHD): Primary Findings from the Phase 3, Randomized REACH3 Study 2021 ·Transplantation and Cellular Therapy ·Robert Zeiser, Nicola Polverelli, Ron Ram, Shahrukh K. Hashmi, Ronjon Chakraverty, Peter Langmuir, Norbert Hollaender, (unknown), Tommaso Stefanelli, Franco Locatelli, Takanori Teshima, Stephanie J. Lee	1
10	Efficacy and Safety of Betibeglogene Autotemcel (beti-cel; LentiGlobin for β-thalassemia) Gene Therapy in 60 Patients with Transfusion-Dependent β-Thalassemia (TDT) Followed for up to 6 Years Post-Infusion 2021 ·Transplantation and Cellular Therapy ·Suradej Hongeng, Alexis A. Thompson, Janet L. Kwiatkowski, Franco Locatelli, John B. Porter, John E.J. Rasko, Marina Cavazzana, Martin G. Sauer, Adrian J. Thrasher, Isabelle Thuret, Ashutosh Lal, Andreas E. Kulozik, Evangelia Yannaki, Manfred Schmidt, (unknown), Ruiting Guo, Weijian Liu, Richard A. Colvin, Mark C. Walters	1
11	Application of Boolean Algebra (Mathematical Logic) for Definition of Acute Leukemias 2021 ·Gerhard Zugmaier, Franco Locatelli, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown)	1
12	Adoptive Immunotherapy Using PRAME-Specific T Cells in Medulloblastoma 2018 ·Cancer Research ·Domenico Orlando, Evelina Miele, Biagio De Angelis, Marika Guercio, Iolanda Boffa, Matilde Sinibaldi, Agnese Pò, Ignazio Caruana, Luana Abballe, Andrea Carai, Simona Caruso, Antonio Camera, Annemarie Moseley, Renate S. Hagedoorn, Mirjam H.M. Heemskerk, Felice Giangaspero, Angela Mastronuzzi, Elisabetta Ferretti, Franco Locatelli, Concetta Quintarelli	56
13	PD-L1 Is a Therapeutic Target of the Bromodomain Inhibitor JQ1 and, Combined with HLA Class I, a Promising Prognostic Biomarker in Neuroblastoma 2017 ·Clinical Cancer Research ·Ombretta Melaiu, Marco Mina, Marco Chierici, Renata Boldrini, Giuseppe Jurman, Paolo Romania, Valerio D’Alicandro, (unknown), Aurora Castellano, Tao Liu, Cesare Furlanello, Franco Locatelli, Doriana Fruci	93
14	Influence of Cranial Radiotherapy on Outcome in Children With Acute Lymphoblastic Leukemia Treated With Contemporary Therapy 2016 ·Journal of Clinical Oncology ·Ajay Vora, Anita Andreano, Ching‐Hon Pui, Stephen P. Hunger, Martin Schrappe, Anja Moericke, Andrea Biondi, Gabriele Escherich, Lewis B. Silverman, Nicholas Goulden, Mervi Taskinen, Rob Pieters, Keizo Horibe, Meenakshi Devidas, Franco Locatelli, Maria Grazia Valsecchi	75
15	ERAP1 Regulates Natural Killer Cell Function by Controlling the Engagement of Inhibitory Receptors 2015 ·Cancer Research ·Loredana Cifaldi, Paolo Romania, Michela Falco, Silvia Lorenzi, Raffaella Meazza, Stefania Petrini, Marco Andreani, Daniela Pende, Franco Locatelli, Doriana Fruci	53
16	ADARs and the Balance Game between Virus Infection and Innate Immune Cell Response 2015 ·Current Issues in Molecular Biology ·Sara Tomaselli, Federica Galeano, Franco Locatelli, Angela Gallo	48
17	A registry of HLA ‐typed donors for production of virus‐specific CD 4 and CD 8 T lymphocytes for adoptive reconstitution of immune‐compromised patients 2014 ·Transfusion ·Giuseppina Li Pira, Federico Ivaldi, (unknown), Fabiola Landi, Sergio Rutella, Franco Locatelli, Nicoletta Sacchi, Gino Tripodi, Fabrizio Manca	2
18	Natural Killer Cells Efficiently Reject Lymphoma Silenced for the Endoplasmic Reticulum Aminopeptidase Associated with Antigen Processing 2011 ·Cancer Research ·Loredana Cifaldi, Elisa Lo Monaco, Matteo Forloni, Ezio Giorda, Silvia Lorenzi, Stefania Petrini, Elisa Tremante, Daniela Pende, Franco Locatelli, Patrizio Giacomini, Doriana Fruci	64
19	Survival after T cell–depleted haploidentical stem cell transplantation is improved using the mother as donor 2008 ·Blood ·Martin Stern, Loredana Ruggeri, Antonella Mancusi, Maria Ester Bernardo, Claudia De Angelis, Christoph Bucher, Franco Locatelli, Franco Aversa, Andrea Velardi	161
20	Evidence- and consensus-based practice guidelines for the therapy of primary myelodysplastic syndromes. A statement from the Italian Society of Hematology. 2002 ·PubMed ·Emilio Paolo Alessandrino, Sergio Amadori, Giovanni Barosi, Mario Cazzola, Alberto Grossi, Lucio N. Liberato, Franco Locatelli, Monia Marchetti, Enrica Morra, Paolo Rebulla, Giuseppe Visani, S Tura	141

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact